Weekly Research Analysts’ Ratings Updates for McKesson (MCK)

Several brokerages have updated their recommendations and price targets on shares of McKesson (NYSE: MCK) in the last few weeks:

• 3/5/2026 – McKesson was given a new $970.00 price target by Raymond James Financial, Inc..
• 3/5/2026 – McKesson had its “outperform” rating reaffirmed by Leerink Partners. They now have a $1,085.00 price target on the stock.
• 3/5/2026 – McKesson had its “outperform” rating reaffirmed by Evercore Inc.
• 2/18/2026 – McKesson had its price target raised by Barclays PLC from $960.00 to $1,050.00. They now have an “overweight” rating on the stock.
• 2/10/2026 – McKesson had its price target raised by JPMorgan Chase & Co. from $983.00 to $1,107.00. They now have an “overweight” rating on the stock.
• 2/5/2026 – McKesson was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
• 2/5/2026 – McKesson had its price target raised by TD Cowen from $1,000.00 to $1,012.00. They now have a “buy” rating on the stock.
• 2/5/2026 – McKesson had its price target raised by Wells Fargo & Company from $914.00 to $925.00. They now have an “equal weight” rating on the stock.
• 2/5/2026 – McKesson had its price target raised by Mizuho from $880.00 to $885.00. They now have a “neutral” rating on the stock.
• 1/29/2026 – McKesson had its “overweight” rating reaffirmed by Morgan Stanley. They now have a $966.00 price target on the stock.
• 1/14/2026 – McKesson was given a new $968.00 price target by Robert W. Baird.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is presently 9.43%.

Insiders Place Their Bets

In related news, EVP Michele Lau sold 2,725 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president directly owned 3,247 shares in the company, valued at $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the sale, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 3,868 shares of company stock worth $3,743,820. Company insiders own 0.08% of the company’s stock.

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.